A total of 8 analyst ratings have been received for Elevance Health, with the consensus rating being Outperform. The average ...

Elevance Health (NYSE:ELV) on Thursday issued its preliminary financial results for Q1 2025, projecting $9.61 of GAAP net ...

For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

Shares of Elevance Health, Inc. (ELV) were in the spotlight on Thursday afternoon after the company said it expects to report ...

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

UnitedHealth Group is seen as the pacesetter for Medicare Advantage, but some analysts view its poor first quarter as an ...

Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs. its $11.63. The company cites medical costs ...

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. “First quarter ...

UnitedHealth said it was blindsided by rising medical costs as the first quarter closed, upending a forecast it had affirmed ...

Healthcare ETFs split as insurers stumble and pharma surges -- highlighting the necessity of smart industry picks.

Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs.